HIF-Prolyl Hydroxylase Regulates Prolyl Hydroxylation and HIF-Mediated Signaling

Target Name: Hypoxia-Inducible Factor Prolyl Hydroxylase

NCBI ID: P18302

Hypoxia-Inducible Factor Prolyl Hydroxylase

Other Name(s): HIF-prolyl hydroxylase | Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase

HIF-Prolyl Hydroxylase Regulates Prolyl Hydroxylation and HIF-Mediated Signaling

Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-prolyl hydroxylase) is a protein that plays a critical role in the regulation of cellular processes that are essential for life. The protein is a key component of the hypoxia-inducible factor (HIF) complex, which is a protein-protein interaction that regulates various cellular processes in response to changes in oxygen levels. HIF is a transcription factor that plays a crucial role in the regulation of gene expression, and it is closely associated with the response to changes in oxygen levels.

HIF-prolyl hydroxylase is a non-species specific subunit of the HIF complex that is involved in the regulation of prolyl hydroxylation, which is a chemical modification that involves the addition of a water molecule to a specific amino acid residue. Prolyl hydroxylation is a critical modification that helps to regulate the stability and activity of various cellular proteins. HIF-prolyl hydroxylase is also involved in the regulation of the HIF-mediated signaling pathway, which is a complex regulatory network that is involved in the regulation of various cellular processes.

HIF-prolyl hydroxylation is a critical modification that helps to regulate the stability and activity of various cellular proteins. Many cellular proteins are modified with prolyl hydroxylation, and these modifications play a critical role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. Prolyl hydroxylation is also involved in the regulation of various cellular signaling pathways, including the HIF-mediated signaling pathway.

HIF is a transcription factor that plays a crucial role in the regulation of gene expression. It is closely associated with the response to changes in oxygen levels and is involved in the regulation of various cellular processes that are essential for life. HIF is activated in response to changes in oxygen levels, and it regulates the expression of various genes that are involved in the regulation of oxygen homeostasis.

HIF-prolyl hydroxylase is a non-species specific subunit of the HIF complex that is involved in the regulation of prolyl hydroxylation. It is a key component of the HIF-mediated signaling pathway and plays a critical role in the regulation of various cellular processes. HIF-prolyl hydroxylation is also involved in the regulation of the stability and activity of various cellular proteins and is a potential drug target or biomarker.

In conclusion, Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-prolyl hydroxylase) is a protein that plays a critical role in the regulation of cellular processes that are essential for life. It is a key component of the HIF complex and is involved in the regulation of prolyl hydroxylation, which is a critical modification that helps to regulate the stability and activity of various cellular proteins. HIF-prolyl hydroxylation is also involved in the regulation of the HIF-mediated signaling pathway and is a potential drug target or biomarker. Further research is needed to fully understand the role of HIF-prolyl hydroxylase in the regulation of cellular processes and to develop effective therapies that target this protein.

Protein Name: Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified Subtype)

The "Hypoxia-Inducible Factor Prolyl Hydroxylase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Hypoxia-Inducible Factor Prolyl Hydroxylase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets